Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2324]
News [5460]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for...
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013
New targets for squamos cell carcinoma
Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany
New targets for squamos cell carcinoma ( Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany )
16 May 2013
European Thoracic Oncology Platform
Dr Solange Peters - Lausanne University, Switzerland
European Thoracic Oncology Platform ( Dr Solange Peters - Lausanne University, Switzerland )
16 May 2013
Diagnosis and treatment in rare cases of thymoma
Dr Walter Klepetko - Vienna Medical University, Austria
Diagnosis and treatment in rare cases of thymoma ( Dr Walter Klepetko - Vienna Medical University, Austria )
16 May 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Next wave of successful drug therapy strategies in HER2-positive breast cancer
Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013
Genetic and clinical factors best for predicting late recurrence in oestrogen...
Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
Measurement variation influences gene expression profiles of breast cancer
Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013
Treatment of non-small cell lung cancer and adenocarcinoma
Dr Keith Kerr – University of Aberdeen, UK
Treatment of non-small cell lung cancer and adenocarcinoma ( Dr Keith Kerr – University of Aberdeen, UK )
15 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation